Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2005;112:2501-2509
doi: 10.1161/CIRCULATIONAHA.105.542829
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tirziu, D.
Right arrow Articles by Simons, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tirziu, D.
Right arrow Articles by Simons, M.
Related Collections
Right arrow Gene therapy
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
Right arrow Growth factors/cytokines

(Circulation. 2005;112:2501-2509.)
© 2005 American Heart Association, Inc.

Vascular Medicine

Delayed Arteriogenesis in Hypercholesterolemic Mice

Daniela Tirziu, PhD; Karen L. Moodie, DVM; Zhen W. Zhuang, MD; Katie Singer, RALAT; Armin Helisch, MD; Jeff F. Dunn, PhD; Weiming Li, PhD; Jaipal Singh, PhD; Michael Simons, MD

From the Angiogenesis Research Center, Section of Cardiology (D.T., K.L.M., Z.W.Z., K.S., A.H., M.S.), Departments of Medicine (D.T., K.L.M., Z.W.Z., K.S., A.H., M.S.), Pharmacology & Toxicology (M.S.), and Radiology (J.F.D.), Dartmouth Medical School, Lebanon, NH, and Eli Lilly & Co, Indianapolis, Ind (W.L., J.S.).

Correspondence to Michael Simons, MD, Section of Cardiology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756. E-mail michael.simons{at}dartmouth.edu

Received February 14, 2005; revision received July 25, 2005; accepted July 27, 2005.

Background— Hypercholesterolemia has been reported to inhibit ischemia-induced angiogenesis. To address its effects on arteriogenesis, we investigated arterial growth in hypercholesterolemic low-density lipoprotein receptor–/–/ApoB-48–/– (HCE) mice.

Methods and Results— The extent and the time course of arteriogenesis after femoral artery ligation was evaluated in HCE and strain-matched control mice. Distal limb perfusion was measured by laser Doppler imaging, whereas MRI was used to visualize arterial flow and micro-computed tomography to assess vascular growth. After femoral artery ligation, serial laser Doppler imaging demonstrated significantly delayed restoration of perfusion in untreated HCE compared with control mice (day 3, 0.09 versus 0.19, P<0.05). Treatment with Ad-PR39 in control mice led to a significant restoration of arterial blood flow and tissue perfusion at day 3, whereas in HCE mice, hindlimb perfusion began increasing only by day 7. Micro-CT analysis confirmed increased growth of smaller arterioles (16 to 63 µm in diameter) in the Ad-PR39–treated control compared with HCE mice. The delay in arteriogenesis in HCE mice correlated with delayed tissue appearance of F4/80+ cells. Analysis of gene expression after Ad-PR39 treatment demonstrated that HCE mice had significantly reduced expression of FGF receptor 1, hypoxia-inducible factor-1{alpha}, vascular cell adhesion molecule-1, macrophage scavenger receptor-1, and cyclophilin A compared with controls 3 days after arterial ligation that equalized by day 7, mimicking relative changes in arteriogenesis and tissue perfusion.

Conclusions— Hypercholesterolemia results in delayed native arteriogenesis because of reduced early monocyte/macrophage influx and delayed and impaired arterial growth response to growth factor therapy.

 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
 CirculationHome page
J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al.
Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography
Circulation, February 19, 2008; 117(7): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Zbinden, L. C. Clavijo, B. Kantor, H. Morsli, G. A. Cortes, J. A. Andrews, G. J. Jang, M. S. Burnett, and S. E. Epstein
Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1891 - H1897.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
V. van Weel, M. de Vries, P. J. Voshol, R. E. Verloop, P. H.C. Eilers, V. W.M. van Hinsbergh, J. H. van Bockel, and P. H.A. Quax
Hypercholesterolemia Reduces Collateral Artery Growth More Dominantly Than Hyperglycemia or Insulin Resistance in Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1383 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
W. Li, W. Shen, R. Gill, A. Corbly, B. Jones, R. Belagaje, Y. Zhang, S. Tang, Y. Chen, Y. Zhai, et al.
High-Resolution Quantitative Computed Tomography Demonstrating Selective Enhancement of Medium-Size Collaterals by Placental Growth Factor-1 in the Mouse Ischemic Hindlimb
Circulation, May 23, 2006; 113(20): 2445 - 2453.
[Abstract] [Full Text] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.